SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001472375-22-000008
Filing Date
2022-01-18
Accepted
2022-01-18 15:36:26
Documents
12
Period of Report
2022-01-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ixform8k.htm   iXBRL 8-K 17656
  Complete submission text file 0001472375-22-000008.txt   185378

Data Files

Seq Description Document Type Size
2 SCHEMA DOCUMENT rep1357878-20220114.xsd EX-101.SCH 2744
3 LABELS LINKBASE DOCUMENT rep1357878-20220114_lab.xml EX-101.LAB 34927
4 PRESENTATION LINKBASE DOCUMENT rep1357878-20220114_pre.xml EX-101.PRE 22830
6 EXTRACTED XBRL INSTANCE DOCUMENT ixform8k_htm.xml XML 3349
Mailing Address 5348 VEGAS DRIVE #177 LAS VEGAS NV 89108
Business Address 5348 VEGAS DRIVE #177 LAS VEGAS NV 89108 (702) 805-7525
REGENEREX PHARMA, INC. (Filer) CIK: 0001357878 (see all company filings)

IRS No.: 980479983 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53230 | Film No.: 22535078
SIC: 2844 Perfumes, Cosmetics & Other Toilet Preparations